Abstract
OBJECTIVE
Carriers of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) demonstrate increased secretion of Cortisol precursors following ACTH stimulation, suggestive of impaired Cortisol production and compensatory increases in hypothalamic corticotropin-releasing hormone (CRH) secretion. Both Cortisol and CRH have behavioral effects, and hypothalamic CRH hypersecretion has been associated with chronic states of anxiety and depression. We performed an endocrinologic and psychological evaluation in carriers of 21-OHD and matched control subjects.
DESIGN
We recruited 29 parents of children with classic CAH (14 males, 15 females; age (mean±SD): 41.8±5.7 yr), and hence 21-OHD carriers, and 13 normal subjects (5 males, 8 females; age: 43.8±6.1 yr). All subjects underwent a formal ovine (o) CRH stimulation test with measurement of ACTH, Cortisol, 17-hydroxyprogesterone (17-OHP) and androstenedione concentrations, which was preceded by determination of 24-hour urinary free Cortisol (UFC) excretion. Psychometric assessment was performed by administering the State-Anxiety (STAI 1) and Trait-Anxiety (STAI 2) Inventory, Beck Depression Inventory, Symptom Checklist-90R and Temperament and Character Inventory.
RESULTS
Carriers of 21-OHD had significantly higher 17-OHP concentrations following oCRH stimulation and higher STAI 1 (47.6±5.6 vs. 43.3±5.4, P=0.023) scores than control subjects. Mean 24-hour UFC concentrations were positively correlated with paranoid ideation (r=0.435; P=0.023) and psychoticism (r=0.454; P=0.017). Stepwise multiple linear regression analysis revealed that the single independent predictor of STAI 1 was peak stimulated 17-OHP concentrations (β: 0.055, SE: 0.023, R2: 0.290, P=0.031).
CONCLUSIONS
Carriers of 21-OHD may be predisposed to the development of anxiety disorders.
Article PDF
Similar content being viewed by others
References
Merke DP, Bornstein SR, 2005 Congenital adrenal hyperplasia. Lancet, 365: 2125–2136.
Speiser PW, White PC, 2003 Congenital adrenal hyperplasia. N Engl J Med 349: 776–788.
Merke DP, Poppas DP, 2013 Management of adolescents with congenital adrenal hyperplasia. Lancet Diabetes Endocrinol 1: 341–352.
Nimkarn S, Lin-Su K, New MI, 2011 Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. Pediatr Clin North Am 58: 1281–1300, xii.
Baumgartner-Parzer SM, Nowotny P, Heinze G, Waldhäusl W, Vierhapper H, 2005 Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab 90: 775–778.
Napolitano E, Manieri C, Restivo F, et al, 2011 Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency. J Endocrinol Invest 34: 498–501.
Charmandari E, Merke DP, Negro PJ, et al, 2004 Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. J Clin Endocrinol Metab 89: 2228–2236.
Chrousos GP, 2009 Stress and disorders of the stress system. Nat Rev Endocrinol 5: 374–381.
Charmandari E, Tsigos C, Chrousos G, 2005 Endocrinology of the stress response. Annu Rev Physiol 67: 259–284.
Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E-M, 2015 Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation 22: 6–19.
Chrousos GP, 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351–1362.
Gold PW, Chrousos GP, 2002 Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol Psychiatry 7: 254–275.
Risbrough VB, Stein MB, 2006 Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav 50: 550–561.
Charmandari E, Kino T, Souvatzoglou E, Chrousos GP, 2003 Pediatric stress: hormonal mediators and human development. Horm Res 59: 161–179.
Kunugi H, Ida I, Owashi, T, et al, 2006 Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology 31: 212–220.
Spielberger CD, 1983 Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press.
Beck AT, Beamesderfer A, 1974 Assessment of depression: the depression inventory. In: Pichot P (ed) Psychological measurements in psychopharmacology. Modern problems in pharmacopsychiatry, Vol 7: Basel, Switzerland: Karger; pp. 151–169.
Derogatis LR, 1983 SCL-90-R: administration, scoring and procedures manual II. Towson, MD: Clinical Psychometric Research.
Cloninger CR, Przybeck TR, Svrakic DM, 1991 The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep 69: 1047–1057.
Fountoulakis KN, Papadopoulou M, Kleanthous S, et al, 2006 Reliability and psychometric properties of the Greek translation of the State-Trait Anxiety Inventory form Y: preliminary data. Ann Gen Psychiatry 5: 2.
Mystakidou K, Tsilika E, Parpa E, Smyrniotis V, Galanos A, Vlahos L, 2007 Beck Depression Inventory: exploring its psychometric properties in a palliative care population of advanced cancer patients. Eur J Cancer Care 16: 244–250.
Donias S, Karastergiou A, Manos N, 1991 Standardization of the symptom checklist-90-R rating scale in a Greek population. Psychiatriki 2: 42–48.
Fountoulakis KN, Rozsa S, Siamouli M, Moutou K, Pantoula E, Cloninger CR, 2015 Standardization and normative data of the Greek version of the temperament and character inventory (TCI). Ann Gen Psychiatry 14: 28.
Laryea G, Arnett MG, Muglia LJ, 2012 Behavioral Studies and Genetic Alterations in Corticotropin-Releasing Hormone (CRH) Neuro circuitry: Insights into Human Psychiatric Disorders. Behav Sci (Basel, Switzerland) 2: 135–171.
Gold PW, Chrousos GP, 2013 Melancholic and atypical subtypes of depression represent distinct pathophysiological entities: CRH, neural circuits, and the diathesis for anxiety and depression. Mol Psychiatry 18: 632–634.
Ising M, Holsboer F, 2007 CRH-sub-1 receptor antagonists for the treatment of depression and anxiety. Exp Clin Psychopharmacol 15: 519–528.
Holsboer F, Ising M, 2008 Central CRH system in depression and anxiety—evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583: 350–357.
Habib KE, Weld KP, Rice KC, et al, 2000 Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Nati Acad Sci USA 97: 6079–6084.
Ayala AR, Pushkas J, Higley JD, et al, 2004 Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm. J Clin Endocrinol Metabol 89: 5729–5737.
Zoumakis E, Rice KC, Gold PW, Chrousos GP, 2006 Potential uses of corticotropin-releasing hormone antagonists. Ann NY Acad Sci 1083: 239–251.
Bao AM, Meynen G, Swaab DF, 2008 The stress system in depression and neuro degeneration: focus on the human hypothalamus. Brain Res Rev 57: 531–553.
Faravelli C, Lo Sauro C, Godini L, et al, 2012 Childhood stressful events, HPA axis and anxiety disorders. World J Psychiatry 2: 13–25.
Yehuda R, Seckl J, 2011 Minireview: Stress-related psychiatric disorders with low Cortisol levels: a metabolic hypothesis. Endocrinology 152: 4496–4503.
Mantella RC, Butters MA, Amico JA, et al, 2008 Salivary Cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 33: 773–781.
Penninx BW, Beekman AT, Bandinelli S, et al, 2007 Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis. Am J Geriatr Psychiatry 15: 522–529.
Vreeburg SA, Hoogendijk WJ, DeRijk RH, et al, 2013 Salivary Cortisol levels and the 2-year course of depressive and anxiety disorders. Psychoneuroendocrinology 38: 1494–1502.
Tsigos C, Chrousos GP, 2002 Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53: 865–871.
Hori H, Ozeki Y, Teraishi T, et al, 2010 Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults. J Psychiatr Res 44: 865–873.
Nelson JC, Davis JM, 1997 DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 154: 1497–1503.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kyritsi, EM., Koltsida, G., Farakla, I. et al. Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormones 16, 42–53 (2017). https://doi.org/10.14310/horm.2002.1718
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.14310/horm.2002.1718
